Trexquant Investment LP Relay Therapeutics, Inc. Transaction History
Trexquant Investment LP
- $8.06 Billion
- Q4 2024
A detailed history of Trexquant Investment LP transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 978,137 shares of RLAY stock, worth $3.91 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
978,137
Previous 411,862
137.49%
Holding current value
$3.91 Million
Previous $2.92 Million
38.22%
% of portfolio
0.05%
Previous 0.04%
Shares
10 transactions
Others Institutions Holding RLAY
# of Institutions
208Shares Held
162MCall Options Held
102KPut Options Held
28.8K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$112 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15MShares$60.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$42.2 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.95MShares$35.8 Million3.17% of portfolio
-
Tang Capital Management LLC San Diego, CA8.07MShares$32.3 Million2.5% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $481M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...